DeCure for Robinow syndrome, autosomal recessive 2
DeCure's autonomous Rare AI scientist is researching a drug-repurposing hypothesis for robinow syndrome, autosomal recessive 2 — screening already-approved drugs against its 1-gene Open Targets disease module to publish open-access research. Research is fast; the path to publication is funded in milestone stages.
Disease moduleRobinow syndrome, autosomal recessive 2 maps to a 1-gene Open Targets module — the target space DeCure's AI scientist screens approved drugs against.
DeCure.ai methodSignature reversal (LINCS) plus network proximity (STRING) rank already-approved drugs likely to perturb this module — the same engine that produces DeCure.ai's repurposing hypotheses.
Repurposing thesisScreening approved medicines against this disease module, then publishing the evidence for the strongest candidate. Known pharmacology and human exposure data make the first question sharper — they do not establish safety or efficacy in a new indication.
Research record
01
ResearchComing soon
Candidate research + dossier — target rationale, drug-repurposing thesis and evidence pack.proof: Published dossier + on-chain hash
02
ValidationComing soon
In-vitro biological validation at a contract research org (CRO).proof: CRO contract + in-vitro report
03
Peer review & paperComing soon
Peer-reviewed paper published open-access (preprint + journal).proof: DOI + open-access link + on-chain hash
Current lead
No approved-drug candidate for robinow syndrome, autosomal recessive 2 is corroborated in the literature DeepSearch retrieved. Some conditions are managed with non-pharmacological care — a device, surgery or physical therapy — rather than a medicine; that may be the case here, or the literature we found may simply be too sparse yet to support a drug-repurposing angle.
What the evidence adds up to
Robinow syndrome is a rare genetic condition with dominant and recessive forms. The autosomal recessive form is caused by mutations in the ROR2 gene. In a 2015 study of 11 Egyptian patients from 7 consanguineous families, five pathogenic ROR2 mutations were identified, four of them novel (G326A, D166H, S677F, and R528Q) and one previously reported (Y192D). The authors suggested a founder effect in the Egyptian population. No treatment or intervention was tested in any of the abstracts.
The syndrome is characterised by short stature, mesomelic limb shortening, genital hypoplasia, and a facial gestalt that includes hypertelorism, a short nose, and a broad mouth. Two sporadic cases described in 2014 also showed axial and appendicular osteosclerosis, which the authors proposed may represent a distinct sub-phenotype. A 1999 report of monozygotic twins with Robinow syndrome noted that both had normal stature, and the authors concluded autosomal dominant inheritance was more likely in that family. A 2016 case report focused on orofacial manifestations in the recessive form, and a 2012 report described neuropathological findings in one patient, including a DNT-like malformation.
No drug, no clinical trial, and no treatment outcome data appear in any of these abstracts. What is missing is any investigation of pharmacological intervention, any trial design, any patient stratification beyond genetic diagnosis, and any funding directed toward therapy development for either form of the syndrome.
Evidence
Retrieved by DeepSearch across 234,678,978 indexed works and resolved on OpenAlex — ranked by citations, including the results that did not work.
American Journal of Medical Genetics Part A · 2014 · 14 citations
An osteosclerotic form of Robinow syndrome
AbstractRobinow syndrome (RS) is a clinically and genetically heterogenous condition primarily characterized by short stature, mesomelia, genital hypoplasia, oral abnormalities, and a facial gestalt that includes hypertelorism, a short nose, and a broad mouth. The disorder exists in both a dominant and a more severe recessive form. Here two unrelated cases of sporadic RS are described with the additional finding of axial and appendicular osteosclerosis. These two patients, coupled with three additional patients previously described in the literature, may represent a distinct sub-phenotype of this condition.
American Journal of Medical Genetics Part A · 2015 · 10 citations
Clinical and molecular characterization of seven Egyptian families with autosomal recessive robinow syndrome: Identification of four novel <i>ROR2</i> gene mutations
AbstractRobinow syndrome (RS) is a rare genetic disorder characterized by limb shortening, genital hypoplasia, and craniofacial/orodental abnormalities. The syndrome follows both autosomal dominant and recessive patterns of inheritance with similar phenotypic presentation and overlapping features. Autosomal recessive Robinow syndrome (ARRS) is caused by mutations in the ROR2 gene. Here, we present the clinical, radiological and molecular findings of 11 Egyptian patients from 7 unrelated consanguineous families with clinical features of ARRS. Mutation analyses of ROR2 gene identified five pathogenic mutations distributed all over the gene. The identified mutations included four novel (G326A, D166H, S677F, and R528Q) and one previously reported (Y192D). Our results extend the number of ROR2 mutations identified so far, suggest a founder effect in the Egyptian population, and emphasize the important role of genetic testing in proper counseling and patients' management.
Robinow syndrome in monozygotic twins with normal stature
AbstractRobinow syndrome was found in two monozygotic twins. We describe the clinical and radiographic manifestations in these patients, both with normal stature and one with omphalocele, with a follow-up of 13 years. Families with Robinow syndrome of both autosomal dominant and recessive inheritance have been reported. We apply the criteria suggested to assign isolated cases to one of the two forms and conclude that autosomal dominant inheritance is more likely.
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · 2016 · 3 citations · open access
Orofacial Manifestations of Autosomal Recessive Robinow’s Syndrome: A Rare Case Report
AbstractRobinow's syndrome is a very rare genetic disorder which bears a resemblance to a foetal face. It is characterized by short-limbed dwarfism, defects in vertebral segmentation and abnormalities in the head, face and external genitalia. It has a genetic heterogeneity with autosomal dominant and recessive forms which relates to the severity of phenotype presentation. A rare case of an autosomal recessive form of Robinow's syndrome is presented with emphasis on, characteristic craniofacial and intraoral manifestations to aid in diagnosis and dental management of this patient.
German Medical Science (German Research Foundation) · 2012 · 0 citations · open access
DNT-like malformation and further neuropathological findings in a patient with Robinow syndrome
AbstractIntroduction: Robinow syndrome includes characteristic facial features, orodental abnormalities, mesomelic shortening of the limbs, a/hypoplasia of phalanges, and hypoplastic genitalia. A dominant form is caused by heterozygous mutation in the WNT5A gene on chromosome 3p14.3 and a recessive form[for full text, please go to the a.m. URL]
Disease module: DeepOracle (Open Targets). Structures: RDKit from PubChem SMILES. Literature: retrieved by DeepSearch across 234,678,978 indexed works (targeted per-candidate search), resolved on OpenAlex.
DeCure is a research and publication project, not medical advice and not a treatment. "DeCure for X" describes a research goal, not a claim that a cure exists. Backing a cure is a contribution to fund the research — it is not an investment, and confers no yield, royalty, equity or IP ownership. Papers are published open-access by the DeCure.ai DAO.
